Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

AstraZeneca, Amgen Breathing Easier with Optimistic Phase III Asthma Drug Results
BioSpace
Mon, 03/1/21 - 11:17 am
Tags:
AstraZeneca, Amgen, clinical trials, severe asthma, asthma, antibodies
Merck inks $1.9B Pandion takeover to square up against Amgen, Lilly and Roche
Fierce Biotech
Thu, 02/25/21 - 10:44 am
Tags:
Merck, Pandion, M&A, immune modulators, Amgen, Eli Lilly, Roche
Amgen Submits Supplemental NDA for Mild-to-Moderate Psoriasis Drug Otezla
BioSpace
Mon, 02/22/21 - 11:49 pm
Tags:
Amgen, Otezla, FDA, psoriasis
Treating COVID-19 long-haulers with Amgen's sleeper heart drug Corlanor
Fierce Biotech
Tue, 02/16/21 - 11:11 am
Tags:
Amgen, Corlanor, COVID-19, COVID-19 long haulers
Amgen loses appeal in patent suit against Sanofi/Regeneron’s Praluent. It’s a bummer for Bristol Myers Squibb and Merck, too
Endpoints
Fri, 02/12/21 - 10:48 am
Tags:
Amgen, patents, Sanofi, Regeneron, Praluent, Repatha, Merck
Amgen cuts 'several hundred' U.S. jobs, primarily sales reps, as COVID-19 speeds a shift to digital
Fierce Pharma
Wed, 02/3/21 - 11:28 pm
Tags:
Amgen, drug reps, layoffs, pandemic, COVID-19
Amgen slams the brakes on a clutch of cancer drugs as reality BiTEs
Fierce Biotech
Wed, 02/3/21 - 10:45 am
Tags:
Amgen, earnings, cancer, oncology, drug development
Amgen Slips Even After Earnings and Revenue Beat Estimates
TheStreet.com
Tue, 02/2/21 - 11:22 pm
Tags:
Amgen, earnings
Amgen study data bolster prospects of KRAS-blocking cancer drug
BioPharma Dive
Thu, 01/28/21 - 11:25 pm
Tags:
Amgen, sotorasib, clinical trials, KRAS mutation, cancer
10 key clinical trials to watch in the first half of 2021
BioPharma Dive
Sun, 01/17/21 - 05:01 pm
Tags:
clinical trials, Novavax, AstraZeneca, JNJ, vaccines, COVID-19, Biomarin, Amgen, Merck, Pfizer, Roche, SAGE Therapeutics, Biogen, Vertex Pharmaceuticals
Amgen ponies up $240M for Michigan discovery outfit's dendritic cell-based molecules for autoimmune disorders
Endpoints
Wed, 01/13/21 - 10:34 am
Tags:
Amgen, autoimmune disease, Evoq Therapeutics
Lilly, Amgen and more back advocacy group's push to double migraine research dollars
Fierce Pharma
Tue, 01/5/21 - 10:52 pm
Tags:
Eli Lilly, Amgen, migraines, Allergan, Novartis, Biohaven, Teva Pharmaceutical
2021 Best Places to Work in Medical Sales
MedReps.com
Tue, 12/22/20 - 10:58 am
Tags:
devices, drug reps, Syneos Health, Teleflex, Avion Pharmaceuticals, Acella, Conmed, Acumed, Lundbeck, Amgen, Biogen, Spark Therapeutics
Amgen-AstraZeneca Experimental Asthma Drug Surprisingly Flops in Phase III
BioSpace
Tue, 12/22/20 - 10:47 am
Tags:
Amgen, AstraZeneca, asthma, clinical trials, tezepelumab
Amgen and Novartis tap TV host to jump-start migraine conversations—and fuel understanding
Fierce Pharma
Wed, 12/16/20 - 10:40 pm
Tags:
Aimovig, Amgen, Novartis, migraines, celebrity endorsements
Could Amgen's Xgeva boost immunotherapy in breast cancer?
Fierce Biotech
Mon, 12/14/20 - 10:37 am
Tags:
Amgen, Xgeva, breast cancer
Vigil Neuroscience launches with a $50M Series A and two former Amgen neuroscience candidates
Endpoints
Tue, 12/8/20 - 10:44 am
Tags:
Vigil Neuroscience, funding, Amgen, Neurosciences
Amgen plans 2020 filing for FDA approval of KRAS drug sotorasib
Fierce Biotech
Tue, 12/8/20 - 10:43 am
Tags:
Amgen, FDA, sotorasib, KRAS
Amgen, Takeda, UCB enroll first patient in Covid-19 global platform study
Pharmaceutical Business Review
Wed, 12/2/20 - 10:24 am
Tags:
COVID-19, pandemic, clinical trials, Takeda, Amgen, UCB, COVID R&D Alliance
Amgen severs 14-year Cytokinetics partnership, bailing on omecamtiv after mixed PhIII results
Endpoints
Mon, 11/23/20 - 10:16 pm
Tags:
Amgen, Cytokinetics, omecamtiv, clinical trials

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.